Incidence of acute serious bacterial infections one year [clinicaltrials_resource:65ef9443dc3658e1c120ab12d429c8b8]
Acute serious bacterial infections are defined in The FDA(CBER) Guidance for industry for studies of IGIV to support marketing of IGIV as replacement therapy for primary humoral immunodeficiency (June, 2008).
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Incidence of acute serious bacterial infections one year [clinicaltrials_resource:65ef9443dc3658e1c120ab12d429c8b8]
Acute serious bacterial infections are defined in The FDA(CBER) Guidance for industry for studies of IGIV to support marketing of IGIV as replacement therapy for primary humoral immunodeficiency (June, 2008).
Bio2RDF identifier
65ef9443dc3658e1c120ab12d429c8b8
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:65ef9443dc3658e1c120ab12d429c8b8
measure [clinicaltrials_vocabulary:measure]
Incidence of acute serious bacterial infections
time frame [clinicaltrials_vocabulary:time-frame]
description
Acute serious bacterial infect ...... immunodeficiency (June, 2008).
identifier
clinicaltrials_resource:65ef9443dc3658e1c120ab12d429c8b8
title
Incidence of acute serious bacterial infections one year
@en
type
label
Incidence of acute serious bac ...... f9443dc3658e1c120ab12d429c8b8]
@en